Fatal Fibrinolysis During Orthotopic Liver Transplantation in Patients Receiving Solvent/Detergent-Treated Plasma (Octaplas)

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 3, 2007, Pages 410-413

  Magner, John J ^a   Crowley, Kieran J ^a   Boylan, John F ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

2 antiplasmin; anesthesiology; anhepatic; aprotinin; bleeding; clotting; fibrinolysis; fresh frozen plasma; Octaplas; orthotopic liver transplantation; solvent detergent treated plasma; tissue plasminogen activator

Indexed keywords

APROTININ; DETERGENT; FRESH FROZEN PLASMA; OCTAPLAS; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ADULT; ANAPHYLAXIS; ARTICLE; ASYSTOLE; BLOOD CLOTTING DISORDER; BRADYCARDIA; CARDIOGENIC SHOCK; CASE REPORT; DRUG WITHDRAWAL; FATALITY; FIBRINOLYSIS; HEMOLYSIS; HUMAN; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TACHYCARDIA;

ADULT; DETERGENTS; FATAL OUTCOME; FEMALE; FIBRINOLYSIS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA; PLASMA EXCHANGE; SOLVENTS; VIRUS DISEASES;

EID: 34249717261     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2006.09.002     Document Type: Article

References (11)

1. Cacciarelli T.V., Keeffe E.B., Moore D.H., et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 134 (1999) 25-29
2. Hellstern P., Sachse H., Schwinn H., et al. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma. Vox Sang 63 (1992) 178-185
3. Doyle S., O'Brien P., Murphy K., et al. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coag Fibrinolysis 14 (2003) 283-287
4. Hellstern P. Solvent/detergent-treated plasma: composition, efficacy, and safety. Curr Opin Hematol 11 (2004) 346-350
5. Mast A.E., Stadanlick J.E., Lockett J.M., et al. Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity. Blood 94 (1999) 3922-3927
6. de Jonge J., Groenland T.H., Metselaar H.J., et al. Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP). Anesth Analg 94 (2002) 1127-1131
7. Freeman J.W., Williamson L.M., Llewelyn C., et al. A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation. Vox Sang 74 suppl 1 (1998) 225-229
8. Williamson L.M., Llewelyn C.A., Fisher N.C., et al. A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 39 (1999) 1227-1234
9. Solheim B.G., Bergan A., Brosstad F., et al. Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP/Octaplas). Anesth Analg 96 (2003) 1230-1231
10. Porte R.J. Coagulation and fibrinolysis in orthotopic liver transplantation: Current views and insights. Semin Thromb Hemost 19 (1993) 191-196
11. Segal H.C., Hunt B.J., Cottam S., et al. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin. Transplantation 58 (1994) 1356-1360